CBD

CBD is the second most common Cannabinoid from the plant of cannabis.

CB1

CB1 is the main Cannabinoid receptor in the brain but is also found in other tissues. CB1 is a G protein-coupled receptor which inhibits adenylyl cyclase and consequently reduces cAMP upon activation. This in turn regulates many second messenger pathways. 

CBDV

CBDV is a non-psychoactive Cannabinoid with anti-convulsant properties like its homolog CBD. It has also other potential therapeutic properties as antitumorigenic, anti-acne and antiemetic effects.

Psychosis and Schizophrenia

schizophrenia is a chronic mental disorder that affects around 1% of the worldwide population. It causes psychotic behaviors, social and emotional disruptions and different cognitive impairments.

The causes of the disease are still not clear but studies show that both genetic and environmental factors have an effect on it.

Epilepsy

cannabinoids have excellent therapeutic potential for the treatment of epilepsy. In the brain, the endocannabinoid system tends to keep neuronal activity wihtin acceptable boundaries.

PTSD

Posttraumatic stress disorder is considered a mental disorder caused after traumatic experiences like traffic accidents, violent circumstances, rape, warfare, etc. Typical symptoms include Anxiety, nightmares, flashbacks and trauma-related cues.

TRPV3

TRPV3 is one of the non-GPCR-coupled Cannabinoid receptors. TRPs are typically involved in pain sensation.

TRPM8

TRPM8 is involved in sensory perception.

TRPA1

TRPA1 is best known as a sensor for environmental irritants, pain, cold and stretch.

Nav1.5

Nav1.5 is a sodium channel that is primarily found in cardiac muscle where it is responsible for action potential generation/cardiac muscle contraction. Nav1.5 is not a classic Cannabinoid receptor but its activity is modulated by cannabinoids.